Health IT Product News Report – February 2022
Allied Market Research reports that the global healthcare information technology (IT) market size was valued at $250,577.15 million in 2020, and is projected to reach $880,688.75 million by 2030, registering a CAGR of 13.3% from 2021 to 2030.
Data Bridge Market Research reports the market drivers and growth can be attributed to the increase in technological know-how, growing volume of patient data, and demand for quick and efficient healthcare processes and systems will help in driving the growth of the healthcare IT market. Increasing digitization in the healthcare industry and demand for value based care and rising cost of provision of healthcare services coupled with the increasing number of healthcare facilities will likely accelerate the growth of the healthcare IT market in the forecast period of 2020-2027.
Health IT Product News:
Vibrent Health Powers NIH Precision Nutrition Research Project to Accelerate Discoveries in Food and Dietary Patterns
Vibrent Health (@VibrentHealth), a health technology startup powering the future of precision health research, announced that the company’s Digital Health Solutions Platform (DHS Platform) will support the National Institutes of Health (NIH) Common Fund’s Nutrition for Precision Health, powered by the All of Us Research Program (NPH). The NPH will explore the dietary health of All of Us participants to inform the development of evidence-based, personalized nutrition recommendations. The NIH is awarding $170 million over five years, pending the availability of funds, to clinics and centers across the country to conduct the study.
Force Therapeutics Achieves Record Growth in Case Volume and Provider Utilization in 2021
Force Therapeutics (@FORCETherEx), a patient engagement platform and research network, announced record growth in the number of patients and providers using its episode of care management platform.
Biotricity receives FDA 510(k) clearance for its Biotres Cardiac Monitoring Device
Biotricity Inc. (@biotricity_inc), a medical diagnostic and consumer healthcare technology company, reported it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.
DxCG Intelligence Celebrates 25th Anniversary, Launches Version 6.0 with Enhanced Clinical and Pharmaceutical Classification Systems
Cotiviti (@Cotiviti) is celebrating the 25th anniversary of DxCG Intelligence, the healthcare industry standard in risk assessment and predictive modeling, by introducing major enhancements to enable healthcare organizations to more accurately measure risk and improve care for their populations. Containing enhanced clinical and pharmaceutical classification systems including an expanded set of Hierarchical Condition Categories (HCCs), DxCG Intelligence v6.0 expands social determinants of health (SDoH) classifications to identify health plan members experiencing socioeconomic and psychosocial difficulties such as homelessness, poverty, and abuse. The latest release also features newly recalibrated models based on the latest benchmark data for commercial, Medicare, and Medicaid populations.
In KLAS report, DeliverHealth’s patient engagement solution earns top satisfaction scores as providers seek to deliver an effective digital front door
DeliverHealth (@deliverhs), a global provider of technology-enabled solutions for hospitals, health systems and group practices, announced that its mobile-first patient engagement software has earned top customer satisfaction scores in a KLAS Emerging Technology Spotlight report.
Vim Achieves HITRUST Risk-based, 2-year Certification to Further Validate Compliance and Security in Point-of-Care Integration Platform
Vim (@getvim), a technology company building digital infrastructure for U.S. healthcare, has earned Certified status for information security by HITRUST. HITRUST Risk-based, 2-year (r2) Certified status demonstrates that key implemented systems within the organization are HITRUST certified and are appropriately managing risk.
Telemedicine Product News:
Quest Diagnostics Launches Virtual Preventive Care Service Through QuestDirect™ to Help Individuals Take Control of Their Health
Adults across the country can now access comprehensive virtual preventive care without visiting a doctor’s office through the new Comprehensive Health Profile from QuestDirect™ the consumer-initiated testing platform from Quest Diagnostics (@QuestDX). This new offering evaluates more than 100 health-related data points — combining access to the same laboratory tests doctors order, a behavioral health risk assessment and biometric measurements, such as weight and blood pressure, to give individuals a personalized snapshot of their overall health.
Mitera Launches Peaches&Me and 23Pears At-Home Genetic Tests
Mitera, a telehealth company focused on reproductive health, announced the launch of its at-home reproductive genetic testing products, Peaches&Me™ and 23Pears™, in all 50 states. Peaches&Me is the first non-invasive prenatal test (NIPT) that can be requested online directly by patients themselves and administered from home. It screens for conditions such as Down syndrome and predicts fetal sex as early as 10 weeks of pregnancy.
Trailblazing Telemedicine Provider CallonDoc Makes Access to Affordable Healthcare Easier with At-Home Test Kits and Free Delivery
CallonDoc (@callondoc_com), a healthcare provider that gives patients the ability to consult with experienced doctors from the comfort of their own homes, now offers at-home testing kits with free front-door delivery. Priced from $35-$50, the kits enable users to test themselves for various health conditions including diabetes, cholesterol, thyroid, kidney and liver problems and STDs. Each multi-specimen kit arrives in a pre-paid box enabling users to send their specimen(s) to the lab and receive the results within 3-5 days via a patient account containing information and next steps. In the event of a positive result, treatment for the specified condition(s) is included in the price of each kit.
COVID-19 Product News:
Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration
The Biden-Harris Administration has brought two new over-the-counter, at-home COVID-19 tests to the U.S. market. The tests, one manufactured by SD Biosensor and distributed by Roche and the other manufactured by Siemens, have received emergency use authorization (EUA) by the Food and Drug Administration (FDA) after being evaluated through the Administration’s new accelerated pathway to support FDA review of tests with potential for large-scale manufacturing that the Department of Health and Human Services (HHS) announced just two months ago.
FDA Medical Devices approved in 2021
The FDA regulates medical devices sold in the United States to assure their safety and effectiveness. Medical devices range from simple tongue depressors and hospital gowns to complex programmable pacemakers and robotic surgical systems. Their Medical Device Product Classification database lists over 6,000 types of medical devices regulated by FDA’s Center for Medical Devices and Radiological Health (CDRH) and the classification assigned to each type. Depending on the device classification, along with other factors, federal regulations (such as the Code of Federal Regulations, Title 21) define requirements that must be fulfilled for CDRH to approve or clear devices sold in the United States.
Here are all of the approved devices from 2021.
